Correlation Between Clearside Biomedical and Virtus Investment

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Clearside Biomedical and Virtus Investment at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clearside Biomedical and Virtus Investment into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clearside Biomedical and Virtus Investment Partners, you can compare the effects of market volatilities on Clearside Biomedical and Virtus Investment and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clearside Biomedical with a short position of Virtus Investment. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clearside Biomedical and Virtus Investment.

Diversification Opportunities for Clearside Biomedical and Virtus Investment

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Clearside and Virtus is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Clearside Biomedical and Virtus Investment Partners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virtus Investment and Clearside Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clearside Biomedical are associated (or correlated) with Virtus Investment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virtus Investment has no effect on the direction of Clearside Biomedical i.e., Clearside Biomedical and Virtus Investment go up and down completely randomly.

Pair Corralation between Clearside Biomedical and Virtus Investment

Assuming the 90 days trading horizon Clearside Biomedical is expected to generate 2.38 times more return on investment than Virtus Investment. However, Clearside Biomedical is 2.38 times more volatile than Virtus Investment Partners. It trades about 0.03 of its potential returns per unit of risk. Virtus Investment Partners is currently generating about 0.06 per unit of risk. If you would invest  89.00  in Clearside Biomedical on September 1, 2024 and sell it today you would earn a total of  12.00  from holding Clearside Biomedical or generate 13.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Clearside Biomedical  vs.  Virtus Investment Partners

 Performance 
       Timeline  
Clearside Biomedical 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Clearside Biomedical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain primary indicators, Clearside Biomedical unveiled solid returns over the last few months and may actually be approaching a breakup point.
Virtus Investment 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Virtus Investment Partners are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Virtus Investment reported solid returns over the last few months and may actually be approaching a breakup point.

Clearside Biomedical and Virtus Investment Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Clearside Biomedical and Virtus Investment

The main advantage of trading using opposite Clearside Biomedical and Virtus Investment positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clearside Biomedical position performs unexpectedly, Virtus Investment can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virtus Investment will offset losses from the drop in Virtus Investment's long position.
The idea behind Clearside Biomedical and Virtus Investment Partners pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk